12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Company News  |  Other News

Forest Laboratories generics, pharmaceuticals news

Activist investor Carl Icahn announced plans to nominate a slate of directors for election to Forest's board for the second straight year. Eric Ende, who was a member of Icahn's failed slate last year, is the only...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >